# FDA Inspection 778063 - Eversight - April 20, 2012

Source: https://www.keypedia.com/records/fda_inspections/eversight/c44a75a2-2166-4253-8f55-0159115ee0fe
Source feed: FDA_Inspections

> FDA Inspection 778063 for Eversight on April 20, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 778063
- Company Name: Eversight
- Inspection Date: 2012-04-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 987521 - 2016-10-07](https://www.keypedia.com/records/fda_inspections/eversight/88fee666-8634-426d-bedf-ca9a8ba78226)
- [FDA Inspection 871148 - 2014-03-21](https://www.keypedia.com/records/fda_inspections/eversight/ceac29c0-f7ae-4d7b-b135-c789ee1bb313)
- [FDA Inspection 635950 - 2009-12-15](https://www.keypedia.com/records/fda_inspections/eversight/e8bc70d8-5b4e-4271-a449-ebb8b43c9cb9)

Company: https://www.keypedia.com/companies/eversight/2d04f832-e665-491b-af4e-dd7bffa24eaf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d